Daily Stock List
Wild Craze, Inc. (WILD)
We are highlighting Wild Craze, Inc. (WILD), here at the QualityStocks Daily Newsletter.
Wild Craze, Inc. designs, develops and manufactures fashion accessory and fashion accessory platforms that attach to clothing and fit flush to a broad spectrum of fabric. The SnapTagz platform can be decorated or it can serve as a mount for other decorated parts like toys and jewelry.
The Company formerly went by the name Wired Associates Solutions, Inc. They changed their name to Wild Craze, Inc. in May of 2012. Incorporated in 2003, in the State of Nevada, Wild Craze has their corporate headquarters in Brooklynn, New York. The Company's shares trade on the OTC Bulletin Board.
The Company originally formed as a multimedia/marketing enterprise that specializes in the design and creation of effective marketing products and services, primarily internet based. During December of 2011, they ceased to engage in the multimedia and marketing industry and acquired the business of SnapTagz, LLC to engage in the production, distribution and marketing of fabric accessories. At present, Wild Craze is in a development stage and the Company has not started their revenue generation strategy.
The Company is a consumer products holding enterprise. Their vision is to build a diversified portfolio of brands that are unique, proprietary, and on-trend. Their plan is to develop the "evergreen" brands of the future in the toy, novelty, as well as leisure segments.
Wild Craze plans to bring their products to the market directly as well as by continuing to secure additional strategic licenses with suppliers in the toy and fashion accessory market.
The Company's SnapTagz is a wholly owned subsidiary of Wild Craze. SnapTagz is a new and innovative toy and fabric accessory protected by two granted patents. Currently, it is undergoing deployment domestically and globally. The SnapTagz platform enables the Company to work with many different designs and verticals in entertainment, sports, and music by marketing to various demographics.
Wild Craze, Inc. (WILD), closed Monday's trading session at $1.00, even for the day. The average volume for the last 60 days is 115 and the stock's 52-week low/high is $0.26/$1.00.
Graphite Corp. (GRPH)
Pro-Edge, Paragon Report, Pumps and Dumps, Penny King, KO PENNY STOCKS, PennyAuthority.com, ElitePennyStocks, Penny Stock Buyers, Momentum Hunter, Penny Lane Reports, and Eastwind Research reported recently on Graphite Corp. (GRPH), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Graphite Corp. is an exploration stage company focusing on the evaluation, acquisition and development of United States graphite mining opportunities. The Company is positioning itself to emerge as a leading pure-play exploration company through the development of their current strategic land positions in Alabama and Montana spanning the heartland of America's most noteworthy graphite resources. Graphite lists on the OTC Market's OTCQB; the Company has their headquarters in Elko, Nevada.
The Company's experienced geological team continues to pursue additional prospective graphite, precious metal, and rare earth opportunities. In Alabama, the Company's acreage is in Clay County, near the towns of Ashland and Lineville. This acreage is 3,759 acres of primarily forestland in two main blocks (Cahaba 2967.9 acres and Carr 791.7 acres). Graphite entered into an option agreement for 100 percent of the mining interests in a Property known as the Carr Leases and the Cahaba Forest Management Leases.
Pertaining to the terms and conditions of the Option Agreement, a production royalty is held by the lessor equal to two percent of the net smelter returns (NSR). Additional provisions of the agreement allow the Company to acquire, further, 50 percent of the property royalty in the future.
In Montana, the Crystal Graphite property is in Beaverhead County, located towards the southern end of the Ruby Range, approximately10 miles east of Dillon, at an altitude of approximately 7,500 feet. The Company has approximately 100 acres collectively known as the Montana Property. The Minerals Lease Agreement (including 3 percent Net Smelter Royalty) gives the Company the right to conduct mineral exploration activities on and in certain land and mining claims, for a term of 25 years with the right to renew.
In December, Graphite announced the inclusion of Mr. Roger W. Szelmeczka to advise the Company on environmental matters. Mr. Szelmeczka is currently the Project Manager at the Southern USA Resources, Inc. "No.1" gold mine in Clay County, Alabama. He brings more than 20 years of experience and demonstrated knowledge with progressive responsibility in regulatory compliance, environmental science, groundwater, hazardous materials management, waste management, emergency response, and emergency management.
Graphite Corp. (GRPH), closed Monday's trading session at $0.57, down 2.56%, on 316,352 volume with 153 trades. The average volume for the last 60 days is 483,306 and the stock's 52-week low/high is $0.20/$1.05.
Cereplast, Inc. (CERP)
Stock Analyzer and Wallstreetlivechat reported this month on Cereplast, Inc. (CERP), SmarTrend Newsletters, StreetInsider, Alliance Advisors, Alternative Energy, PennyTrader Publisher, OTCPicks did earlier, and we report on the Company today, here at the QualityStocks Daily Newsletter.
Founded in 2001, Cereplast, Inc. is a leading manufacturer of proprietary biobased, sustainable bioplastics. Headquartered in El Segundo, California, the Company designs and manufactures proprietary biobased, sustainable bioplastics used as substitutes for traditional plastics in all major converting processes (e.g. injection molding, thermoforming, blow molding and extrusions), at a pricing structure that is competitive with traditional plastics. Cereplast offers resins to meet an assortment of customer demands.
Cereplast Compostables® resins are ideally suited for single-use applications where high biobased content and compostability are advantageous. This is particularly in the food service industry. Cereplast Sustainables® resins combine high biobased content with the durability and endurance of traditional plastic, making them ideal for applications in industries such as automotive, consumer electronics as well as packaging.
The Company's focus is on innovation and environmental sustainability. Cereplast works to deliver the highest quality bio-based materials made from renewable resources such as corn, potatoes, tapioca, sugar and algae. Their family of resins offers the similar physical benefits of petroleum-based plastics while also helping to protect and preserve the environment.
Cereplast has their RezInnovation™ initiative. This is a focus on bioplastic resin innovation and a dedication to research and development. RezInnovation™ also involves a commitment to positively affecting the future of plastics and the planet through sustainable technology and manufacturing.
Cereplast has also introduced the first algae-based plastic products. The design of Cereplast Algae-Bioplastics is to replace up to 50 percent or more of the petroleum content used in traditional plastic resins. Algae has the ability to absorb and minimize greenhouse gases from the industrial process, creating up to 45 percent fewer greenhouse gases than traditional plastics.
Last month, Cereplast announced the commercialization of Cereplast Algae Bioplastics™ with the introduction of Biopropylene® 109D. Biopropylene 109D is an injection-molding grade manufactured with 20 percent post-industrial algae biomatter. The renewable resource content greatly reduces the carbon footprint of the final product while reducing the petroleum-based plastic content.
The Company identified a post-industrial algae source that does not rely on the commercialization of biofuel production. This allows them to commercialize Cereplast Algae Bioplastics sooner than anticipated. Furthermore, the Cereplast Research and Development team discovered a post-industrial process that substantially reduces the odor that is normally inherent to algae biomatter.
Cereplast, Inc. (CERP), closed Monday's trading session at $0.0126, down 11.27%, on 5,630,512 volume with 148 trades. The average volume for the last 60 days is 1,455,311 and the stock's 52-week low/high is $0.014/$0.054.
CGX Energy, Inc. (OYL.V)
Wall Street Reporter and AllPennyStocks reported previously on CGX Energy, Inc. (OYL.V), and we highlight the Company today, here at the QualityStocks Daily Newsletter.
CGX Energy, Inc. is an oil and gas exploration company whose shares trade on the TSX Venture Exchange. The Company focuses on the exploration of oil in the Guyana-Suriname Basin. CGX holds four licenses in this basin, a frontier basin in South America with a proven hydrocarbon system and highly prospective deep-water plays that can be drilled in shallow water. CGX Energy has their headquarters in Toronto, Ontario.
The United States Geological Survey (USGS) has identified the Guyana Suriname basin as having the second highest resource potential among unexplored oil basins in the world. They estimate mean recoverable oil reserves of over 13.6 billion bbls and gas reserves of 39 trillion cubic ft.
CGX Energy is pursuing the Equatorial Atlantic Margin Play, analogous to West Africa and Brazil. The Company has over 10 prospects and leads and independent P50 resource estimates of 3 billion barrels of potential resources. The Company's licenses in Guyana cover 7.8 million acres gross, 6.2 million acres net. CGX Energy is the seventh largest landholder in Latin America.
In late November 2012, CGX Energy announced that they transitioned to a new Corentyne petroleum agreement (Corentyne PA) and petroleum prospecting license (Corentyne PPL) offshore Guyana effective as of November 27, 2012, renewable after four years for up to ten years. The new Corentyne PA applies to the former offshore portion of the Corentyne PPL, covering 6,212 square kilometers.
The basis of the license is on Guyana's revised specimen agreement but with terms and conditions similar to the former Corentyne PA. Under the terms of the new Corentyne PA, and during the initial period of four years, CGX Energy has an obligation to drill two wells. Application has also been made by CGX for new PA's to be issued for the former Annex PPL, the onshore portion of the Corentyne PPL, and the Berbice PPL.
Recently, CGX Energy announced that the Board of Directors appointed Mr. Suresh Narine as Executive Chairman of CGX. Mr. Narine joined the Board of CGX on January 3, 2012; he was appointed Chairman on May 4, 2012. With his involvement expanding beyond usual Chairman responsibilities, the Board of Directors made the appointment to Executive Chairman effective immediately. A team of experienced oil and gas and finance professionals from Guyana, Canada, the United States and the United Kingdom manage CGX Energy.
CGX Energy, Inc. (OYL.V), closed Monday's trading session at $0.19, up 11.76%, on 281,863 volume. The stock's 52-week low/high is $0.14/$1.55.
European Uranium Resources Ltd. (EUU.V)
Today we are highlighting European Uranium Resources Ltd. (EUU.V), here at the QualityStocks Daily Newsletter.
Trading on the TSX Venture Exchange, European Uranium Resources Ltd. is a dedicated European uranium exploration and development company with corporate headquarters in Vancouver, British Columbia. The Company has a strong base of shareholders including AREVA, ranked first in the worldwide nuclear power industry and a key player in uranium mining and nuclear operations on a global basis. European Uranium Resources has built a portfolio of premier projects in Slovakia, Sweden and Finland at all stages of the exploration/development pipeline.
The Company’s Kuriskova Project in Slovakia could be one of the world's lowest cost uranium producers. Slovakia is the world's third largest per capita user of nuclear energy. Nuclear power provides more than 50 percent of their electricity. At present, four nuclear reactors are operating at two plants, with two additional reactors under construction. Slovakia does not presently produce any uranium. Europe's only producing uranium mine is in the Czech Republic.
Recently, European Uranium Resources reported that they signed a Memorandum of Understanding (MoU) with the Ministry of Economy of the Slovak Republic. The MoU defines the parameters by which the Company and the Ministry of Economy will cooperate in advancing the Kuriskova uranium deposit, on which the Company holds the exploration license, via ongoing feasibility and environmental studies.
A Preliminary Feasibility Study completed by Tetra Tech, Inc. indicates that the Kuriskova uranium deposit can undergo development as an underground mine using Best Available Technologies with minimal environmental impact. European Uranium Resources' ongoing Feasibility Study and Environmental Impact Assessment will concentrate on demonstrating that the Kuriskova deposit can undergo development as an environmentally sustainable and commercially viable project.
The Company and the Ministry of Economy of the Slovak Republic agree that if the Feasibility Study and Environmental Impact Assessment are positive, then the Project will be able to advance in agreement with the Slovak Republic's National Energy Strategy. A key point of the MoU is that if the Kuriskova project enters the mining phase, it should undergo development in a way that demonstrably increases energy independence of the Slovak Republic, will have positive effects on economic interests of the Slovak Republic and will create new jobs in eastern Slovakia.
European Uranium Resources Ltd. (EUU.V), closed Monday's trading session at $0.32, up 10.34%, on 58,986 volume. The stock's 52-week low/high is $0.17/$0.60.
MacroSolve, Inc. (MCVE)
OtcWizard, PennyStockNewsletter.info, Corporate Profile Media, The Momentum Traders Network, Premium Stock Picks, Stock Exploder, Day Trade Alert, StockGuru, and FeedBlitz reported earlier on MacroSolve, Inc. (MCVE), and we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Founded in 1997, MacroSolve, Inc. is an OTCQB-listed company with a robust intellectual property (IP) portfolio. They are advancing throughout the mobile applications era by innovating key technologies that have laid the foundation for apps and next-generation developers. MacroSolve has their headquarters in Tulsa, Oklahoma.
The Company is a leading developer and marketer of mobile technologies. They leverage their IP portfolio, including their landmark patent, and generate revenues via licensing and consulting. MacroSolve has a history of landmark achievements ranging from patent #7,822,816, to the creation and recent sale of the Illume Mobile division, the formation and sale of the DigiTicket division, as well as other product ventures. Their business strategy, with the sale of the Illume division, is focusing on taking advantage of their IP strength and corporate experience, specifically through undertaking new ventures with growth-oriented target companies seeking market intelligence and mentorship.
Concerning Revenue Streams, at present, the expectation is that patent license royalties and settlements from enforcement actions will continue throughout the life of the '816' patent, which expires in 2025. Additional patent licensing revenues will come from DecisionPoint as they continue growing Illume Mobile across the country.
MacroSolve believes that commission revenues and other success fees may come from DecisionPoint by MacroSolve's sourcing new customers and synergistic businesses. MacroSolve's strategy also includes future license revenues and consulting fees generated by executing the new strategy with targeted mobile app companies.
Last month, MacroSolve announced that they executed a reciprocal business development agreement with Fiksu, Inc., developer of the award-winning Fiksu for Mobile Apps Marketing Platform that combines advanced optimization technology with the world's largest mobile app media inventory. The agreement streamlines go-to-market app store strategies for MacroSolve's clients. Fiksu clients can access MacroSolve's business advisory support in preparation for a campaign or accelerated understanding of the business app ecosystem.
MacroSolve, Inc. (MCVE), closed Monday's trading session at $0.025, down 7.41%, on 20,000 volume with 2 trades. The average volume for the last 60 days is 128,286 and the stock's 52-week low/high is $0.012/$0.135.
Horiyoshi Worldwide, Inc. (HHWW)
Epic Stock Picks, StocksGoneWild, and Secret Stock Club reported earlier on Horiyoshi Worldwide, Inc. (HHWW), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Horiyoshi Worldwide, Inc. is a clothing and accessories design and distribution company whose shares trade on the OTCBB. The inspiration for the Company's products is the artwork of Japanese master tattoo artist Yoshihito Nakano - better known as Horiyoshi III. The business established on September 1, 2008 to capitalize on the multi-generational legacy of the Tattoo Masters by offering consumers a unique collection of knitwear, t-shirts and accessory items. Horiyoshi Worldwide is based in Los Angeles, California.
The Company started selling their products in 2009. The rights to the Horiyoshi III design catalogue are exclusively licensed to Horiyoshi the Third, Inc. (HTT) a wholly owned subsidiary of Horiyoshi Worldwide. Horiyoshi Worldwide [U.K.] Ltd., another subsidiary wholly owned by Horiyoshi Worldwide, was established in 2011 and operates the Company's first branded retail outlet in London.
Horiyoshi Worldwide introduces quality clothes that infuse the globally recognized artwork of Horiyoshi III. They believe they are at the vanguard of a growing interest in unique aspects of the art and cultural imagery of the Far East. Their corporate strategy includes the development of a line extension marketed at a lower price point and focused on larger markets. In tandem, several new distribution channels are under development. The Company's objective is to build a brand that has recognition worldwide for creating quality products with universal appeal.
In December 2011, the Company launched the "Heroes & Demons" collection of men's t-shirts, which retail at a suggested price point of $50-$75. In July 2012, Horiyoshi Worldwide launched "The Thiiird" collection of men's t-shirts, denims, sweats and hoodies. The Thiiird retails at a suggested price point of approximately $79-$97 for t-shirts, $196-$304 for denims, and $214-$293 for sweats and hoodies. The Company sells their products through apparel retailers, and through the Horiyoshi and Heroes & Demons branded Websites.
For the three months ended September 30, 2012, Horiyoshi Worldwide reported net sales of $376,428. This represents an increase of $110,382, or 41 percent, more than the $266,046 reported for the quarter ended September 30, 2011. Gross margin increased to 48 percent for the quarter ended September 30, 2012 compared to -28 percent for the quarter ended September 30, 2011. Net loss for the quarter ended September 30, 2012 was $499,444 compared to a net loss of $1,005,343 for the quarter ended September 30, 2011.
Horiyoshi Worldwide, Inc. (HHWW), closed Monday's trading session at $0.04, down 42.86%, on 1,675 volume with 3 trades. The average volume for the last 60 days is 4,566 and the stock's 52-week low/high is $0.0148/$0.60.
Goldrich Mining Co. (GRMC)
StockEgg, PennyInvest, HotOTC, CoolPennyStocks, PennyStockVille, MadPennyStocks, StockRich, BullRally, and AllPennyStocks reported earlier on Goldrich Mining Co. (GRMC), and we highlight the Company, here at the QualityStocks Daily Newsletter.
Listed on the OTCBB, Goldrich Mining Co. is a precious metals exploration and development company. The Company focuses on Alaska's emerging Chandalar gold district, 190 miles north of Fairbanks. The Chandalar district is in the prolific Ambler Schist belt that hosts many world-class deposits. The Company's wholly owned Chandalar and adjacent Thazzik Mountain properties consist of approximately 22,840 acres and 25,600 acres, respectively. Goldrich Mining is based in Spokane, Washington.
Earlier exploration at Chandalar has identified more than 40 bedrock gold anomalies over a 5-mile by 2.5-mile northeast trending belt. Goldrich Mining has discovered evidence of Carlin-type sediment-hosted and orogenic, low-sulphide mesothermal gold targets.
The Company has 100 percent ownership of the entire Chandalar district. It consists of a contiguous land-block totaling 36 square miles consisting of 23 patented claims and 164 unpatented State of Alaska claims. Significant infrastructure is in place at Chandalar. This includes a 25-person camp, an alluvial wash plant, heavy equipment, a 4,400-foot (1.3 km) airstrip, and a 30-mile (48-km) network of roads.
The Thazzik Mountain claims are 30 miles southeast of Goldrich Mining's current Chandalar claims. Historical USGS geophysical and geochemical data showed anomalous gold, arsenic, and antimony present at Thazzik Mountain.
This past November, Goldrich Mining reported that Goldrich NyacAU Placer, LLC (GNP), a 50/50 joint-venture company owned by Goldrich and NyacAU, LLC (NyacAU) and operated by NyacAU, successfully completed the work necessary to begin production at Goldrich Mining's Alaskan Chandalar Property at the start of the 2013 field season. The production goal for 2013 is 8,500 ounces of fine gold and approximately 10,000 ounces per season subsequently.
Total production could substantially increase if a second gold recovery plant is installed in the future. Goldrich Mining forecasts that cash production costs for 2013 will be less than $700 per ounce of gold.
In December, Goldrich Mining announced that they successfully completed the sale of on-site equipment at their Chandalar gold property for $900,000 to an affiliate of NyacAU. The equipment will remain at the mine site; it will be leased by Goldrich NyacAU Placer, LLC (GNP), for the production of gold at Chandalar. The sale of the equipment amends the Joint Venture agreement in which Goldrich Mining would have leased the equipment, with a book value of $1.2 million, over five years to GNP.
Goldrich Mining Co. (GRMC), closed Monday's trading session at $0.11, up 37.50%, on 460 volume with 1 trade. The average volume for the last 60 days is 26,322 and the stock's 52-week low/high is $0.052/$0.185.
GlobalWise Investments, Inc. (GWIV)
The QualityStocks Daily Newsletter would like to spotlight GlobalWise Investments, Inc. (GWIV). Today, GlobalWise Investments, Inc. closed trading at $0.34, up 6.25%, on 33,200 volume with 9 trades. The stock’s average daily volume over the past 60 days is 9,296, and its 52-week low/high is $0.18/$1.87.
GlobalWise Investments reported the upcoming launch of a new sales campaign with its channel partner Tiburon. This campaign, which is expected to kick off in the next three weeks, will target Tiburon’s client base of over 600 leading public safety agencies in North America. GlobalWise’s Intellivue™ platform has already proven its ability to win new clients for Tiburon, and the companies are very excited to further expand the existing relationship by targeting a far greater number of government agencies.
GlobalWise Investments, Inc. (GWIV), via wholly-owned subsidiary Intellinetics, Inc., is a leading-edge technology company focused on Enterprise Content Management (ECM) solutions for the digital age. The ECM industry continues to grow rapidly as a result of unrestricted proliferation of digital content within today's business environment. Leveraging its proprietary cloud-based computing software, GlobalWise is poised to capture a significant market share of this burgeoning industry.
GlobalWise's ECM service is delivered to customers via five unique delivery models which cover the spectrum of business needs: Cloud/Saas (Software as a Service), Hardware Vendor Integrated Service, Software Vendor Integrated Service, Premise (Client-Server), Hybrid (Premise & Cloud/Saas).This diversity gives advanced security & privacy features with an on-demand structure needed for large Tier 3 and Tier 4 businesses that are currently underserved by the market.
The Intellinetics platform defines a new industry benchmark and game-changing approach by combining advanced virtualization & automated content management with an open and service-oriented architecture using web services. The company provides strategies, tactics, and technologies used to manage paper and digital assets from capture to long-term archive, without the need for manual processes conducted by a full time employee.
GlobalWise's management boasts a combined total of over 60 years in ECM leadership and industry experience. The ECM industry is expected to exceed $5.1 billion by 2013 with Gartner predicting a compound annual growth rate of 9.5%. IBM Market Insights predicts adoption of cloud computing to grow by 26% CAGR between 2010 through 2013. Leveraging management and key department heads, Intellinetics has a strong foundation from which to capture significant market share within the lucrative $149 billion Business Software & Services industry. Disclaimer
GlobalWise Investments Company Blog
GlobalWise Investments News:
GlobalWise Launching Sales Campaign With Public Safety Market Leader Tiburon
GlobalWise Enters New Channel Sales Partnership With Iron Data
GlobalWise Announces Board Changes
VIASPACE, Inc. (VSPC)
The QualityStocks Daily Newsletter would like to spotlight VIASPACE, Inc. (VSPC). Today, VIASPACE, Inc. closed trading at $0.011, off by 1.79%, on 1,510,444 volume with 34 trades. The stock’s average daily volume over the past 60 days is 857,069, and its 52-week low/high is $0.0013/$0.015.
Viaspace, Inc. announced today that the company's proprietary dedicated energy crop, Giant King™ Grass (GKG), is now growing in Hawaii, which currently generates the vast majority of its energy from expensive imported oil. This incredible low-carbon fuel could help to offset the $0.30 to $0.40 per kilowatt hour or more currently paid by residents for electricity (which fluctuates with the oil price), bringing in a high-yield biomass alternative whose plantations and co-located energy plants may even become a major facet of the massive Hawaii tourism industry.
VIASPACE, Inc. (VSPC) is focused on growing renewable Giant King™ Grass as a low-carbon fuel for clean electricity generation and environmentally friendly energy pellets, as well as a feedstock for bio-methane production, green cellulosic biofuels, biochemical, and biomaterials. A high-yield, low-cost feedstock, Giant King Grass meets the cost targets of green energy applications while maintaining a carbon neutral profile.
The highest yielding biomass crop in the world, Giant King Grass can grow in a variety of soil conditions and does not compete with food crops. Once Giant King Grass is established, it can be harvested at 3-5 feet tall every 45 to 60 days or at 14 feet tall twice a year. This incredibly high rate of growth provides a continual supply of biomass year-round, enabling strategically located power plants to operate 24 hours a day regardless of the current season.
VIASPACE provides Giant King™ Grass seedlings and technical expertise to qualified projects. The company also plans to serve as a project developer or co-developer for power plant or pellet mill projects, together with local partners that have land and require electricity, heat, pellets, biogas, or biofuels. VIASPACE and its partners are capable of delivering an integrated Giant King Grass plantation and biomass power plant project in just 24 months.
The excellent energy characteristics of Giant King Grass and its ability to be harvested multiple times each year enable and energy output yield that is much higher than other crops . This superior feedstock offers material productivity benefits at remarkable costs for energy production, biofuels, and biomaterials. Giant King Grass is currently being grown in the United States, Virgin Islands, China, and other areas. Disclaimer
VIASPACE, Inc. Company Blog
VIASPACE, Inc. News:
VIASPACE Giant King Grass Energy Crop Growing in Hawaii
VIASPACE CEO Invited to Speak At EUEC2013 Conference and Company to Feature GiantKing™ Grass in Exhibit Hall
St. Croix Giant King Grass-Fueled Electric Power Plant Design Approved by Public Services Commission
VistaGen Therapeutics, Inc. (VSTA)
The QualityStocks Daily Newsletter would like to spotlight VistaGen Therapeutics, Inc. (VSTA). Today, VistaGen Therapeutics, Inc. closed trading at $0.73, up 4.29%, on 600 volume with 1 trade. The stock’s average daily volume over the past 60 days is 1,453, and its 52-week low/high is $0.06/$3.15.
VistaGen Therapeutics, Inc. (VSTA) is a biotechnology company applying stem cell technology for drug rescue and cell therapy. Drug rescue combines human stem cell technology with modern medicinal chemistry to generate new chemical variants ("drug rescue variants") of once-promising drug candidates that have been discontinued during late-stage preclinical development due to heart or liver safety concerns. VistaGen also focuses on cell therapy, or regenerative medicine, which includes repairing, replacing or restoring damaged tissues or organs.
VistaGen's versatile stem cell technology platform, Human Clinical Trials in a Test Tube™, has been developed to provide clinically relevant predictions of potential heart and liver toxicity of promising new drug candidates long before they are ever tested on humans.
By more closely approximating human biology than conventional animal studies and other nonclinical techniques and technologies currently used in drug development, VistaGen's human stem cell-based bioassay systems can improve the predictability of the drug development cycle and lower the cost of new drug research and development by identifying product failures earlier in the cost curve. According to the Food and Drug Administration even only a ten percent improvement in predicting failure before clinical trials could save $100 million in development costs, which savings ultimately could be passed on to patients.
Using mature human heart cells produced from stem cells, VistaGen has developed and internally validated CardioSafe 3D™, a novel three-dimensional (3D) bioassay system for predicting the in vivo cardiac effects of new drug candidates before they are tested in humans. VistaGen is now focused on using CardioSafe 3D™ to generate up to two new, safer small molecule drug rescue variants every twelve to eighteen months. VistaGen anticipates that these drug rescue variants will be modified versions of once-promising new drug candidates that have been discontinued by pharmaceutical companies and academic research institutions because of heart toxicity concerns, despite substantial prior investment and positive efficacy data demonstrating their potential therapeutic and commercial benefits. In most cases, VistaGen plans to license or sell its new, safer drug rescue variants in strategic partnering arrangements with global pharmaceutical companies, arrangements providing VistaGen with both near term and downstream milestone payments and economic participation rights but without future development cost obligations.
VistaGen's lead drug candidate, AV-101, is in Phase Ib development in the U.S. for treatment of neuropathic pain, a serious and chronic condition causing pain after an injury or disease of the peripheral or central nervous system.
Neuropathic pain affects approximately 1.8 million people in the U.S. alone. Although the current active AV-101 IND is for the treatment of neuropathic pain, VistaGen's development plan and regulatory strategy for AV-101 has been designed to allow its Phase 1 safety studies to support Phase 2 development for depression, epilepsy, Huntington's Disease and Parkinson's disease, indications for which there is now supporting preclinical efficacy data. To date, VistaGen has been awarded over $8.5 million from the U.S. National Institutes of Health (NIH) for development of AV-101.
VistaGen is also developing LiverSafe 3D™, a novel predictive liver toxicity and drug metabolism bioassay system for drug rescue applications. In parallel with drug rescue activities, the Company is funding early-stage nonclinical studies focused on potential cell therapy applications of its Human Clinical Trials in a Test Tube™ platform. Disclaimer
VistaGen Therapeutics, Inc. Company Blog
VistaGen Therapeutics, Inc. News:
VistaGen Therapeutics Becomes Member of Centre for Commercialization of Regenerative Medicine Consortium
VistaGen Therapeutics Enhances Predictive Liver Toxicology and Drug Metabolism Bioassay System -- LiverSafe 3D™
VistaGen Therapeutics and Duke University Announce Heart Tissue Engineering Progress at American Heart Association 2012 Scientific Sessions
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.21, even for the day, on 208,235 volume with 49 trades. The stock’s average daily volume over the past 60 days is 141,755, and its 52-week low/high is $0.161/$0.68.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.
A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.
In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
International Stem Cell Corporation Announces Positive Animal Efficacy Results in Liver Disease Program
International Stem Cell Corporation to Participate in Biotech Showcase 2013 on January 7th
Lifeline Skin Care a Subsidiary of ISCO Announces New Sales and Multi-Media Marketing Campaigns
GlobalWise Investments and its wholly owned subsidiary Intellinetics, a leading-edge technology company focused on the design, implementation, and management of cloud-based Enterprise Content Management (“ECM”) systems in both the public and private sectors, today reported the upcoming launch of a new sales campaign with its channel partner Tiburon (www.tiburoninc.com). This campaign, which is expected to kick off in the next three weeks, will target Tiburon’s client base of over 600 leading public safety agencies in North America.
For more than three decades, Tiburon has set the standard of excellence for the delivery of computer aided dispatch, mobility, records management, and corrections management solutions built to meet the rigorous demands of state, local, and federal law enforcement, fire & rescue, and corrections agencies. Tiburon selected Intellinetics as its strategic partner for Enterprise Content Management to further extend the service and value provided to clients. Intellinetics’ combination of advanced, mission-critical technology, public sector experience, and flexible deployment models made it the best ECM partner for Tiburon.
“We are proud to be Tiburon’s ECM provider,” commented William “BJ” Santiago, CEO of GlobalWise. “As a market leader, Tiburon could choose any ECM partner. It is gratifying they selected us to fulfill a critical need within the Public Safety markets in which they serve. The Intellivue™ Total Command Electronic Document Management Solution (ITCE) is an affordable, simple to purchase and install bundle designed exclusively for Tiburon’s TotalCommand client base. With an attractive entry point of approximately $50,000, ITCE will be well received in this space. The Tiburon team has been great to work with throughout the process of integrating all the technical, sales and marketing aspects of this exciting new campaign.”
“Intellinetics has become one of our benchmark partners, setting a high standard for partner support, technology integration and hard work to deliver results,” added Kirke Kurtis, Marketing Director for Tiburon. “The Intellivue™ platform has the unique blend of advanced privacy features, integration flexibility and ease of use that is absolutely vital to our clients. Intellinetics has been an important part of winning new clients for our company, and we are excited to bring that success into our large installed client base.”
For more information on GlobalWise, visit www.GlobalWiseInvestments.com
Today before the opening bell, VIASPACE announced that its proprietary dedicated energy crop, Giant King™ Grass (GKG), is now growing in Hawaii.
“Hawaii has the highest electricity rates of any US state because their electricity is mostly generated from expensive imported oil,” stated VIASPACE CEO Dr. Carl Kukkonen. “Hawaii’s electric rates range from $.30 – $.40 per kilowatt hour depending on the cost of oil. This is two or three times the cost of electricity on the US mainland. Bioelectricity from Giant King Grass is substantially cheaper than oil generated electricity and has much lower carbon emissions. In addition, the large military presence on Hawaii has requirements for liquid biofuels for aircraft and ships. We believe that Hawaii should be an important part of the VIASPACE US strategy.”
Previously it was announced that the US Department of Agriculture Animal and Plant Health Inspection Service (APHIS) released GKG from quarantine for distribution in the United States. Hawaii, however, has additional plant import rules. As a result, the energy crop is being grown in a facility under the purview of the Hawaii Department of Agriculture.
Dr. Kukkonen personally supervised the planting in Hawaii and met with Department of Agriculture officials as well as with potential Giant King Grass customers in Hawaii. According to the CEO, the climate in Hawaii is ideal for GKG. Furthermore, there are substantial tracts of land available on different Hawaiian Islands that were previously used to grow sugarcane and pineapple.
“The Giant King Grass now growing in Hawaii was provided by the VIASPACE nursery in California,” commented VIASPACE Board Chairman Dr. Kevin Schewe. We have recently shipped GKG seedlings from California for projects with three other customers and Dr. Kukkonen is currently out of the country and personally supervising planting of GKG with one of these new customers. We are anxious to announce these projects and are respecting our clients’ internal timelines and needs in this regard. We have graduated from an R&D company and are busy executing our business strategy on a global scale.”
For more information on VIASPACE and its energy crop, visit www.VIASPACE.com
In December of 2012, ISCO subsidiary Lifeline Skin Care, creators of advanced rejuvenating stem cell skin creams, hosted a breakfast for 40+ editors (newspaper, magazine, and online) in New York City. Present were key people from some of the best known publications in the country, including Cosmopolitan, Harper’s Bazaar, New York Times, Redbook, Vogue, and many others. In the case of Vogue, it was one of the first times that the Beauty Director has attended an event like this.
The result of these contacts has been a number of soon to be published articles on Lifeline Skin Care, including follow-up interviews with Dr. Elizabeth Hale, renowned dermatologist, in support of Lifeline Skin Care stem cell skin creams. In a related story, Mariel Hemingway has begun a celebrity endorsement of Lifeline’s Eye Firming Complex on OpenSky.com.
Lifeline is the first human-derived non-embryonic stem cell extract that helps to stimulate collagen and elastin. Below are some additional examples of recent Lifeline exposure:
• CW SAN DIEGO (January 6, 2013) – Linda Nelson, Lifeline Director of Education, was interviewed regarding stem cell skincare products. (Lifeline Skin Care interview)
• EXAMINER.COM (January 8, 2013) – Both Lifeline treatment serums were featured in “5 Fine Living Questions with Supermodel Emme.” What’s particularly important about Examiner.com is that it is the 35th largest website in the USA, with more than 16 million visitors a month. (5 fine living questions with supermodel emme)
• LOVINGYOU.COM (January 8, 2013) – Dr. Simon Craw featured, photographed and quoted as an expert in “Can Stem Cells Help Repair Your Skin?”
• REALBEAUTY.COM (January 10, 2013) – Lifeline Recovery NIGHT Moisture Serum featured and photographed in “Winter Skin Remedies”—with 312,422 readers. (dry winter skin tips)
• STAYING YOUNG SHOW (December 18, 2012) Dr. Craw was interviewed about ISCO’s therapeutic treatments. The show is heard in select markets as well as Sirius radio. Linda Nelson was also interviewed for the show. (Linda Nelson interview).
• STYLE.COM (January 3, 2013) – The Eye Firming Complex was featured and photographed in “Stem Cells In Skincare Get A New Look” (99,147 viewers). (stem cells in skincare get a new look)
• THEZOEREPORT.COM (January 10, 2013) – Lifeline Eye Firming Complex was featured and photographed in “Cell Out” (40,000 readers).
• ZOE BEAUTIFUL NEWSLETTER (January 10, 2013) – Lifeline Eye Firming Complex featured and photographed in “Cell Out” (475,000 readers). (lifeline skin care eye firming complex)
• The Ricki Lake Show – Lifeline was featured on an “anti-aging pajama party.” The show was taped on December 19 and will air in January.
• LifestyleMirror.com, LuckyMag.com, and Glamour.com are all planning stories for January or February.
For additional information, visit www.InternationalStemCell.com and www.LifelineSkinCare.com
Pacific Ethanol, the leading marketer and producer of low-carbon renewable fuels in the Western United States, today announced plans to implement yield-enhancing technology at its Stockton plant. Edenig, a biomaterials sustainable fuels innovator, has been awarded a contract by Pacific Ethanol for its Cellunators™ technology, which will boost ethanol yields by increasing available starch for conversion.
Additionally, the Cellunators™ technology will allow Pacific Ethanol to adopt Edenig’s Pathway™ technology, fully integrating Cellunator with proprietary enzymes to convert the cellulosic fraction of the corn kernel to ethanol, enabling a conventional plant to potentially produce cellulosic ethanol.
“Our agreement with Edenig for its Cellunators technology demonstrates our commitment to improving efficiencies at the plant level and positions us to produce advanced biofuels within a corn ethanol plant,” said Niel Koehler, the company’s president and CEO. “We expect this technology to increase yields and improve overall plant profitability.”
In addition to the production and marketing of low-carbon renewable fuels, Pacific Ethanol also sells co-products, such as wet distillers grain (WDG), a nutritional animal feed. Additionally, Pacific Ethanol provides transportation, storage, and delivery of ethanol through third-party service providers in the Western United States, supplying a valuable service to integrated oil companies and gasoline marketers who blend ethanol into gasoline.
For more information on Pacific Ethanol, visit www.pacificethanol.net
Today's Top 3
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Advaxis, Inc. (ADXS) to Present at the 6th Annual OneMedForum
- Bergamo Acquisition Corp. (BGMO) Signs Investment Agreement
- Consorteum Holdings, Inc. (CSRH) Files Form 10-K Report With the Securities and Exchange Commission
- Cardium Therapeutics, Inc. (CXM) To Present At Biotech Showcase 2013 Investment Conference And Report On New Cardium Initiatives
- The Guitammer Company Inc. (GTMM) Insiders Acquire An Aggregate Of 156,000 GTMM Shares In Open Market Purchases
- GlobalWise Investments, Inc. (GWIV) Launching Sales Campaign With Public Safety Market Leader Tiburon
- International Stem Cell Corp. (ISCO) Announces Positive Animal Efficacy Results in Liver Disease Program
- Loans4Less.com, Inc. (LFLS) Provides Preliminary Financial Results for Year Ended December, 31 2012
- TNI BioTech Inc. (TNIB) Acquires the Exclusive Rights to Low Dose Naltrexone and Other Opioid Antagonists for the Treatment of Inflammatory and Ulcerative Diseases of the Bowel
- Viaspace, Inc. (VSPC) Giant King Grass Energy Crop Growing in Hawaii
- Viscount Systems, Inc. (VSYS) Awarded Contract to Secure New Mexico School District
- VistaGen Therapeutics, Inc. (VSTA) Becomes Member of Centre for Commercialization of Regenerative Medicine Consortium